Pfizer Competitors

PFE -  USA Stock  

USD 54.00  3.11  6.11%

Pfizer Inc competes with Dr Reddys, Trinity Bio, Origin Agritech, Zoetis Inc, and Regeneron Pharmaceuticals; as well as few others. The company runs under Healthcare sector within Drug Manufacturers—General industry. Analyzing Pfizer competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Pfizer to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Pfizer competition on your existing holdings. Please check Pfizer Correlation with its peers.

Pfizer Competition 

 
Refresh
Pfizer Return on Average Assets are projected to increase slightly based on the last few years of reporting. The past year's Return on Average Assets were at 5.98. The current year Return on Average Equity is expected to grow to 15.32, whereas Return on Invested Capital is forecasted to decline to 0.22. Pfizer Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 35.07 Billion. The current year Tax Assets is expected to grow to about 5.8 B, whereas Goodwill and Intangible Assets are forecasted to decline to about 84.3 B.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Pfizer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Pfizer in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
51.9753.9355.89
Details
Intrinsic
Valuation
LowReal ValueHigh
46.1948.1559.40
Details
Naive
Forecast
LowNext ValueHigh
50.5352.5054.46
Details
11 Analysts
Consensus
LowTarget PriceHigh
41.0047.6061.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pfizer. Your research has to be compared to or analyzed against Pfizer's peers to derive any actionable benefits. When done correctly, Pfizer's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Pfizer Inc.

Pfizer Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Pfizer and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Pfizer and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Pfizer Inc does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Pfizer Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Pfizer stock performing well and Pfizer company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Pfizer's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
RDY
 1.01  0.05  0.07  0.29  1.05  0.06 (1.20)  2.26 (1.99)  6.02 
TRIB
 2.37 (0.52)  0.00 (0.99)  0.00 (0.15)  0.00  5.03 (5.99)  18.82 
SEED
 3.79  0.30  0.08  0.26  3.76  0.06 (4.74)  9.24 (7.06)  18.25 
ZTS
 0.91  0.12  0.12  0.15  1.05  0.12 (0.99)  1.66 (1.73)  5.06 
REGN
 1.24 (0.05)  0.00 (0.20)  0.00 (0.0138)  0.00  2.36 (3.10)  11.61 
PRGO
 1.59 (0.08)  0.00 (0.30)  0.00 (0.0217)  0.00  2.91 (2.70)  20.00 
SGEN
 1.50  0.01  0.02  0.02  1.96  0.0179 (1.56)  2.51 (3.59)  7.83 
VRTX
 0.95 (0.12)  0.00 (0.21)  0.00 (0.09)  0.00  2.55 (1.71)  5.89 
SCLN
 0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 

Cross Equities Net Income Analysis

Select Fundamental

201020112012201320142015201620172018201920202021
ZTS
110 M245 M436 M504 M583 M339 M821 M864 M1.4 B1.5 B1.6 B1.8 B
REGN
(104.5 M)(221.8 M)750.3 M424.4 M348.1 M636.1 M895.5 M1.2 B2.4 B2.1 B3.5 B3.8 B
SGEN
(66.3 M)(152 M)(53.8 M)(62.5 M)(76.1 M)(120.5 M)(140.1 M)(125.5 M)(222.7 M)(158.7 M)613.7 M662.1 M
VRTX
(754.6 M)29.6 M(107 M)(445 M)(738.6 M)(556.3 M)(112.1 M)263.5 M2.1 B1.2 B2.7 B2.9 B
SCLN
21.1 M28.5 M9.6 M11 M25.2 M29.5 M30.7 M30.7 M30.7 M30.7 M27.7 M23.9 M

Pfizer Inc and related stocks such as Dr Reddys Laboratories, Trinity Bio ADR, Origin Agritech, Zoetis Inc Cl, Regeneron Pharmaceuticals, Perrigo Company, Seagen Inc, Vertex Pharmaceutic, and SciClone Pharmaceuticals, Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Pfizer Inc financial statement analysis. It represents the amount of money remaining after all of Pfizer Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Pfizer Competitive Analysis

The better you understand Pfizer competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Pfizer's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Pfizer's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PFE
RDY
TRIB
SEED
ZTS
REGN
PRGO
SGEN
VRTX
 6.11 
 54.00 
Pfizer
 2.98 
 62.99 
Dr Reddys
 1.67 
 1.83 
Trinity
 4.86 
 10.15 
Origin
 1.73 
 219.32 
Zoetis
 0.75 
 643.35 
Regeneron
 2.70 
 37.78 
Perrigo
 2.14 
 169.50 
Seagen
 1.42 
 183.59 
Vertex
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Pfizer Competition Performance Charts

Complement your Pfizer position

In addition to having Pfizer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cars Thematic Idea Now

Cars
Cars Theme
Domestic and international companies involved in manufacturing and serving automobiles and trucks. Cars theme has 30 constituents.
View All  Next Launch Cars
Please check Pfizer Correlation with its peers. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.